In the case of mouse models for bone metastasis with prostate cancer cells, genistein reduced the level of MMP-9 [88], while in an orthotopic model of prostate cancer it inhibited metastasis to lymph nodes and lungs [166]. The gene discussed is MMP9; the disease is prostate carcinoma.